首页> 外文会议>International institute of statistics and management engineering symposium >Research on the Effectiveness of Top Management Compensation Encouragement in Driving Biopharmaceutical Enterprise Performance
【24h】

Research on the Effectiveness of Top Management Compensation Encouragement in Driving Biopharmaceutical Enterprise Performance

机译:顶级管理赔偿促进驾驶生物制药企业绩效的有效性研究

获取原文

摘要

In this paper, we study the effectiveness of top management compensation encouragement in driving biopharmaceutical listing enterprise performance in 2006-2008. The results show that percentage of the total compensation in the average annual market value of top management shareholding, per capita total compensation of top management and growth rates of per capita total monetary compensation that top management obtains can promote firm performance significantly. When the population proportion of top management that owns stock is low, the top management stock ownership has a negative impact on firm performance.
机译:在本文中,我们研究了2006 - 2008年推动生物药物上市企业绩效的最高管理补偿鼓励的有效性。结果表明,最高管理股权的平均年度市场价值的总补偿百分比,人均最高管理层的全部薪酬总补偿总体货币补偿,顶级管理层获得的全体货币赔偿可以显着促进公司性能。当拥有股票的最高管理层的人口比例较低时,最高管理层所有权对公司性能产生负面影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号